These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 27605261)

  • 21. microRNA analysis of gastric cancer patients from Saudi Arabian population.
    Bibi F; Naseer MI; Alvi SA; Yasir M; Jiman-Fatani AA; Sawan A; Abuzenadah AM; Al-Qahtani MH; Azhar EI
    BMC Genomics; 2016 Oct; 17(Suppl 9):751. PubMed ID: 27766962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-183-5p acts as a potential prognostic biomarker in gastric cancer and regulates cell functions by modulating EEF2.
    Li W; Cui X; Qi A; Yan L; Wang T; Li B
    Pathol Res Pract; 2019 Nov; 215(11):152636. PubMed ID: 31558304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological and prognostic significance of miR-4317 expression in gastric cancer patients.
    Zhang J; Tian ZL; Zhang WT; Cheng LM; Liu J; Cao YX; Zhang ZR
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2803-2808. PubMed ID: 31002131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-126: An indicator of poor prognosis and recurrence in histologically lymph node-negative gastric cancer.
    Feng R; Sah BK; Li J; Lu S; Yuan F; Jin X; Yan M; Liu B; Li C; Zhu Z
    Cancer Biomark; 2018; 23(3):437-445. PubMed ID: 30248047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased miR-198 expression and its prognostic significance in human gastric cancer.
    Cui Z; Zheng X; Kong D
    World J Surg Oncol; 2016 Feb; 14():33. PubMed ID: 26852230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-15a-5p, A Novel Prognostic Biomarker, Predicting Recurrent Colorectal Adenocarcinoma.
    Kontos CK; Tsiakanikas P; Avgeris M; Papadopoulos IN; Scorilas A
    Mol Diagn Ther; 2017 Aug; 21(4):453-464. PubMed ID: 28405803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The correlation of circulating pro-angiogenic miRNAs' expressions with disease risk, clinicopathological features, and survival profiles in gastric cancer.
    Peng W; Liu YN; Zhu SQ; Li WQ; Guo FC
    Cancer Med; 2018 Aug; 7(8):3773-3791. PubMed ID: 30003708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.
    Liu Y; Luo X; Deng J; Pan Y; Zhang L; Liang H
    Tumour Biol; 2015 Apr; 36(4):2685-94. PubMed ID: 25472580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical value of miR-425-5p detection and its association with cell proliferation and apoptosis of gastric cancer.
    Zhang Z; Wen M; Guo J; Shi J; Wang Z; Tan B; Zhang G; Zheng X; Zhang A
    Pathol Res Pract; 2017 Aug; 213(8):929-937. PubMed ID: 28647207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between microRNA-421 expression level and prognosis of gastric cancer.
    Liu H; Gao Y; Song D; Liu T; Feng Y
    Int J Clin Exp Pathol; 2015; 8(11):15128-32. PubMed ID: 26823855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation of miR-519a Predicts Poor Prognosis and Contributes to Tumor Progression in Gastric Cancer.
    Cai H; Lin H; Cao W; Sun J; Huang Y; Fang Y
    Oncol Res Treat; 2020; 43(1-2):19-26. PubMed ID: 31743914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum miR-200c expression level as a prognostic biomarker for gastric cancer.
    Zhang HP; Sun FB; Li SJ
    Genet Mol Res; 2015 Dec; 14(4):15913-20. PubMed ID: 26662382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-451, a potential prognostic biomarker and tumor suppressor for gastric cancer.
    Su Z; Zhao J; Rong Z; Geng W; Wang Z
    Int J Clin Exp Pathol; 2015; 8(8):9154-60. PubMed ID: 26464660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
    Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
    Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Up-Regulation of Plasma miR-23b is Associated with Poor Prognosis of Gastric Cancer.
    Zhuang K; Han K; Tang H; Yin X; Zhang J; Zhang X; Zhang L
    Med Sci Monit; 2016 Feb; 22():356-61. PubMed ID: 26835790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic and Prognostic Value of Serum MicroRNA-206 in Patients with Gastric Cancer.
    Hou CG; Luo XY; Li G
    Cell Physiol Biochem; 2016; 39(4):1512-20. PubMed ID: 27614739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-18a modulates P53 expression by targeting IRF2 in gastric cancer patients.
    Chen YJ; Wu H; Zhu JM; Li XD; Luo SW; Dong L; Liu TT; Shen XZ
    J Gastroenterol Hepatol; 2016 Jan; 31(1):155-63. PubMed ID: 26173586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor Epigenetic Signature and Survival in Resected Gastric Cancer Patients.
    Woo Y; Behrendt CE; Yang A; Hahn M; Goel A; Li H; Yuan YC; Fong Y
    J Am Coll Surg; 2021 Apr; 232(4):483-491.e1. PubMed ID: 33465468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer.
    Su Y; Lin L; Zhang J; Jiang Y; Pan C; Sun L; Duan J; Liao W
    Mol Med Rep; 2015 Oct; 12(4):5771-9. PubMed ID: 26239822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of miR-1294 is downregulated and predicts a poor prognosis in gastric cancer.
    Shi YX; Ye BL; Hu BR; Ruan XJ
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5525-5530. PubMed ID: 30229824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.